Navigating market access in neuroscience: Challenges and strategies

Leveraging people, processes and technology to deliver for biotech

De-risking Drug Development | Episode 5: Expand the use and value of your product over time

De-risking Drug Development | Episode 4: Implement market launch strategy, pre-approval

Podcast: Accelerated approvals – what’s next, confirmatory trials, access, and pricing

De-risking Drug Development | Episode 3: Plan how to get to market quickly, post proof-of-concept

Enabling Successful Sites Ep. 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training

Enabling Successful Sites Ep. 3: Taking the complexity out of oncology trials

De-risking Drug Development | Episode 2: Focus on safety and efficacy and prove quickly that your product works

De-risking Drug Development | Episode 1: How to drive value in pre-clinical development

Enabling Successful Sites, Episode 1: Solving Site Feasibility and Start-Up Challenges

Rare Endpoints: Delivering on Unmet Patient Needs

Advancing Precision Oncology: Expanding Patient Access to Biomarkers and Testing Capabilities Part 3

Advancing Precision Oncology: Expanding Patient Access to Biomarkers and Testing Capabilities Part 2

Advancing Precision Oncology: Expanding Patient Access to Biomarkers and Testing Capabilities Part 1

CAR-T boxed warnings: What comes next?

Preparing for a Cell and Gene Future | Episode 1: Looking Back at 2023 Achievements

Three trends impacting market access in the EU

How can we advance fair and ethical reimbursement for patients?

Beyond the Binary: Navigating Gender Diversity in Clinical Research